Pazocam 200mg Tablet
By Pazocam
Rx
30 Tablet in a Bottle

Composition
Pazopanib(200mg)

Manufacturer - Medicamen Biotech Ltd
Plot no 84 and 85 , sector 6A , IIE sidcul , bhel , ranipur , Haridwar 249403 ( uttarakhand ) India

Expires on or after
July, 2025

liver
When it comes to using Pazocam 200mg Tablet, it is essential to take precautions if you have liver disease. Patients with liver issues should use this medication with care, as the dose may need to be adjusted. It is advisable to consult your doctor before starting or changing the dose of Pazocam 200mg Tablet. However, if you have moderate to severe liver disease, it is recommended not to use Pazocam 200mg Tablet. Always seek medical advice and guidance to ensure the safe and effective use of this medication.

kidney
Pazocam 200mg Tablet is safe for patients with kidney disease. No dose adjustment is needed. It's safe for kidney cancer patients; dose adjustments may be made by the doctor based on the patient's condition.

alcohol
It is recommended to avoid alcohol consumption with Pazocam 200mg Tablet as it may increase the risk of side effects like dizziness, drowsiness, or difficulty in concentrating. Consult your doctor for advice on alcohol use with this medication.

driving
When taking Pazocam 200mg Tablet, be cautious as it may reduce alertness, affect vision, and cause drowsiness or dizziness. Refrain from driving if experiencing these symptoms. Driving ability while on Pazolong Tablet 30's is unknown.

pregnancy
Pazocam 200mg Tablet is not safe for use during pregnancy, as it poses risks to the developing baby. In certain critical situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor. Restricted in pregnancy, a negative pregnancy test is required before starting treatment. Effective birth control methods should be used during treatment and for 6 months after the last dose.

breastfeeding
Pazocam 200mg Tablet should not be used during breastfeeding as it may cause toxicity to the baby. The drug passes into breast milk, posing a possible risk to the infant. It is advisable for breastfeeding mothers to avoid Pazolong Tablet 30's.
Habit Forming | No |
Chemical Class | Alkyldiarylamines Derivative |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
₹2700
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024